Status:
NOT_YET_RECRUITING
Prognostic Study of Prostate Cancer Via Dynamic Change of PSA in Peritoneal Drainage Fluid After Radical Prostatectomy
Lead Sponsor:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Conditions:
Prostatic Neoplasms
Prostate-Specific Antigen
Eligibility:
All Genders
Brief Summary
This study investigates the prognostic value of dynamic changes in Prostate-Specific Antigen (PSA) levels found in the peritoneal drainage fluid after radical prostatectomy. Prostate cancer is one of ...
Detailed Description
This study examines the prognostic significance of Prostate-Specific Antigen (PSA) levels in the peritoneal drainage fluid following radical prostatectomy, a common surgical treatment for prostate can...
Eligibility Criteria
Inclusion
- Prostate cancer patients treated with radical prostatectomy
Exclusion
- 1\. Received neoadjuvant endocrine/chemotherapy before surgery;
- 2\. Urine leakage after surgery (positive creatinine test of drainage fluid).
Key Trial Info
Start Date :
December 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06608225
Start Date
December 1 2024
End Date
December 1 2024
Last Update
November 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai General Hospital
Shanghai, Shanghai Municipality, China, 200080